Board of Directors

Eugene Wong is a seasoned entrepreneur, investment banker and investor. He serves on several boards and is the Managing General Partner of the Reno Seed Fund. His vast career includes roles as an advisor, director and investor to several companies, including Radixx International, IOTERRA/ Breadware Inc., Kabbage, Veracast Communications, Optimer Pharmaceuticals (IPO), First American International Bank (IPO) and Protection One Alarm Services (IPO).

Eugene enjoys splitting his time between Northern Nevada and California's Bay Area.

Jason has a 20+ year career focused on building and mentoring exceptional teams capable of communicating the benefits of highly technical products with simple and scalable messaging. He is passionate about optimizing the sales message by understanding both the voice of the customer and the environment where the sales interactions occur.

Mick is a biochemist/microbiologist with 35+ years of experience in development of pharmaceuticals, with a particular emphasis on antiviral drugs. He contributes in various roles to many organizations including as a University of Nevada, Reno (UNR) Foundation Trustee as well as an Advisory Council Member at the UNR College of Science and UNR College of Business. He also serves as a board member and advisor for many life science companies.

Edward S. Park, Ph.D., is the Founder and President of NeuroReserve. Ed has over 15 years of experience in the research and development of biopharmaceuticals, medical devices, and nutritional therapeutics. Ed worked with major pharmaceutical and health care companies as an R&D advisor with PricewaterhouseCoopers (PwC) Health Industries Advisory. Before PwC, Ed worked at Altus Pharmaceuticals. Ed started his therapeutics career as an R&D associate at Bristol Myers Squibb. Ed holds a Ph.D. in Chemical-Biomolecular Engineering from the Georgia Institute of Technology, as well as a M.S. and M.B.A. from the Massachusetts Institute of Technology.

For nearly a decade, Del has managed lab automation products that accelerate biopharma drug discovery and development processes.  He has helped develop and maintain automated, high throughput solutions for a variety of biologics and gene therapy workflows with an approach to product that keeps customer needs paramount. He enjoys working with established and newer automation companies to implement product strategies that deliver quality solutions for key improvements, which ultimately help propel scientific discovery of new therapeutics forward.  

Aaron Bonk brings over two decades of invaluable expertise within the Life Sciences industry, currently serving as the Chief Executive Officer at Zeitigen. Known for his profound insights and contributions, Aaron's areas of specialization encompass genomics, molecular biology, sequencing, lab automation, and robotics. Furthermore, he commands expert proficiency in instrumentation and workflows, solidifying his status as a leader in the field.

Justin Ferranto is a distinguished professional holding a Bachelor of Science degree in Physics from the University of California, Davis, complemented by a Masters and PhD in Mechanical Engineering from the University of Nevada, Reno. With a versatile background, Justin has garnered extensive experience across various industries, including Laboratory Automation, Medical Device Manufacturing, Lithium Battery Design and Manufacturing, as well as expertise in Thin Film Deposition and Composite Materials.

Jon is a graduate of the University of Nevada, Reno, where he attained a Bachelor of Science degree in Mechanical Engineering. Possessing a robust background in prototyping and additive manufacturing, Jon also boasts proficiency in computer-aided design software and manufacturing lab equipment. With a solid foundation in mechanical engineering and practical experience in prototyping, Jon is primed to introduce innovative solutions to the Life Sciences market.